Procalcitonin: A Key Marker in Children with Urinary Tract Infection
2011

Procalcitonin as a Marker for Urinary Tract Infections in Children

Sample size: 1011 publication 10 minutes Evidence: moderate

Author Information

Author(s): Leroy Sandrine, Gervaix Alain

Primary Institution: Centre for Statistics in Medicine, University of Oxford

Hypothesis

Can procalcitonin serve as a reliable marker for diagnosing urinary tract infections and predicting complications in children?

Conclusion

Procalcitonin is a reliable marker for diagnosing acute pyelonephritis and predicting renal scarring and high-grade vesicoureteral reflux in children with urinary tract infections.

Supporting Evidence

  • Procalcitonin levels correlate with the severity of bacterial infections.
  • High procalcitonin levels are associated with acute pyelonephritis and renal scarring.
  • Procalcitonin can help differentiate between bacterial and viral infections in children.

Takeaway

Procalcitonin helps doctors figure out if kids with urinary infections have serious kidney problems, which can help them treat them better.

Methodology

The study reviewed various cohort studies and meta-analyses to assess the diagnostic accuracy of procalcitonin for acute pyelonephritis and renal scarring.

Potential Biases

There may be bias related to the methods of urine collection and the variability in diagnostic thresholds across studies.

Limitations

The study highlights the need for further validation studies and the potential for bias in urine collection techniques.

Participant Demographics

Children with urinary tract infections, including both genders and various age groups.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI, 4.6–8.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2011/397618

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication